Application 217679

Type: ANDA
Sponsor: MANKIND PHARMA

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	TICAGRELOR	TICAGRELOR	TABLET;ORAL	60MG	No	No
002	TICAGRELOR	TICAGRELOR	TABLET;ORAL	90MG	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A217679-001	TICAGRELOR	TICAGRELOR	60MG	TABLET / ORAL	AB		2026-02-06
A217679-002	TICAGRELOR	TICAGRELOR	90MG	TABLET / ORAL	AB		2026-02-06

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A217679-001	AB
A217679-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A217679-001	TICAGRELOR	60MG	TABLET / ORAL	AB	2026-02-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A217679-002	TICAGRELOR	90MG	TABLET / ORAL	AB	2026-02-06	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A217679-001	TICAGRELOR	60MG	TABLET / ORAL	AB	2026-02-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A217679-002	TICAGRELOR	90MG	TABLET / ORAL	AB	2026-02-06	`011fe1cb6892…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A217679-001	TICAGRELOR	60MG	TABLET / ORAL	AB	2026-02-06	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A217679-002	TICAGRELOR	90MG	TABLET / ORAL	AB	2026-02-06	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A217679-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A217679-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A217679-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A217679-002	AB	1	`011fe1cb6892…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A217679-001	AB	1	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A217679-002	AB	1	`a50c72e98297…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ticagrelor	TICAGRELOR	Lifestar Pharma LLC	7efe86fa-5d19-413a-8b15-e51279b62f3f	2026-05-26	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 217679 application number: ANDA217679

Documents#

Document, Submission type, Date table
Document	Submission type	Date
84986	ORIG	2026-02-11